Yanxin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yanxin Wu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Zilian Wang
Department of Obstetrics and Gynecology, The first affiliated hospital, Sun Yat-sen University, Guangzhou, China
2 shared publications - Casper J. P. Zhang
School of Public Health, The University of Hong Kong, Hong Kong, China (Hong Kong)
1 shared publication - Cong Sun
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
1 shared publication Dongyu Wang
Department of Obstetrics, The First Affiliated Hospital, Sun Yat-sen University
1 shared publication- Haitian Chen
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat- Sen University,Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases, No. 58 Zhongshan Second Road, Yuexiu District, Guangzhou, 510080, China.
1 shared publication - Hanqing Chen
Department of Obstetrics and Gynaecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510060, China
1 shared publication
Latest Publications
- Open Access
- 20 May 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1715392
Gut microbiota-derived short-chain fatty acids attenuate placental ferroptosis and insulin resistance in gestational diabetes via the ACSL4/LPCAT3 pathway
Objective: Gestational diabetes mellitus (GDM) is associated with gut microbiota dysbiosis and placental dysfunction. This study aimed to investigate whether gut microbiota-derived short-chain fatty acids (SCFAs) ameliorate placental injury and insulin resistance in GDM by suppressing ferroptosis, a novel form of iron-dependent cell death. Methods: A GDM rat model was induced by streptozotocin, and gut microbiota was depleted via a broad-spectrum antibiotic cocktail. Physiological parameters, gut microbiota composition, and SCFA levels were assessed. Placental and metabolic tissues were analyzed for ferroptosis markers (Fe 2+ , MDA, ROS), key regulatory enzymes (GPX4, ACSL4, LPCAT3), polyunsaturated fatty acid (PUFA) profiles, and inflammation. An in vitro insulin resistance model in human trophoblast cells (HTR-8/SVneo) was used to validate the causal role of SCFAs. Results: GDM and antibiotic-induced dysbiosis led to a significant depletion of SCFA-producing bacteria and reduced colonic SCFA levels. This was concomitant with severe placental ferroptosis, characterized by iron accumulation, lipid peroxidation, and downregulation of GPX4 alongside upregulation of ACSL4 and LPCAT3. PUFA substrates were significantly consumed, and systemic inflammation was elevated. In vitro , insulin resistance induced trophoblast ferroptosis and dysfunction, which was effectively rescued by SCFA treatment. SCFAs restored GPX4 expression, suppressed ACSL4/LPCAT3, preserved PUFAs, and attenuated inflammation. Conclusion: Gut microbiota-derived SCFAs play a critical protective role in GDM by inhibiting the ACSL4/LPCAT3-mediated ferroptotic pathway in placental trophoblasts, thereby improving insulin sensitivity and mitigating cellular injury. Our findings highlight the gut-placenta axis as a potential therapeutic target for GDM, warranting further validation in human studies.
- 20 May 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1715392
Open AccessGut microbiota-derived short-chain fatty acids attenuate placental ferroptosis and insulin resistance in gestational diabetes via the ACSL4/LPCAT3 pathway
Objective: Gestational diabetes mellitus (GDM) is associated with gut microbiota dysbiosis and placental dysfunction. This study aimed to investigate whether gut microbiota-derived short-chain fatty acids (SCFAs) ameliorate placental injury and insulin resistance in GDM by suppressing ferroptosis, a novel form of iron-dependent cell death. Methods: A GDM rat model was induced by streptozotocin, and gut microbiota was depleted via a broad-spectrum antibiotic cocktail. Physiological parameters, gut microbiota composition, and SCFA levels were assessed. Placental and metabolic tissues were analyzed for ferroptosis markers (Fe 2+ , MDA, ROS), key regulatory enzymes (GPX4, ACSL4, LPCAT3), polyunsaturated fatty acid (PUFA) profiles, and inflammation. An in vitro insulin resistance model in human trophoblast cells (HTR-8/SVneo) was used to validate the causal role of SCFAs. Results: GDM and antibiotic-induced dysbiosis led to a significant depletion of SCFA-producing bacteria and reduced colonic SCFA levels. This was concomitant with severe placental ferroptosis, characterized by iron accumulation, lipid peroxidation, and downregulation of GPX4 alongside upregulation of ACSL4 and LPCAT3. PUFA substrates were significantly consumed, and systemic inflammation was elevated. In vitro , insulin resistance induced trophoblast ferroptosis and dysfunction, which was effectively rescued by SCFA treatment. SCFAs restored GPX4 expression, suppressed ACSL4/LPCAT3, preserved PUFAs, and attenuated inflammation. Conclusion: Gut microbiota-derived SCFAs play a critical protective role in GDM by inhibiting the ACSL4/LPCAT3-mediated ferroptotic pathway in placental trophoblasts, thereby improving insulin sensitivity and mitigating cellular injury. Our findings highlight the gut-placenta axis as a potential therapeutic target for GDM, warranting further validation in human studies.
- Open Access
- 12 November 2018
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 18 (1) , 1-9
The effect of exercise during pregnancy on gestational diabetes mellitus in normal-weight women: a systematic review and meta-analysis
Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy, and it has both short- and long-term adverse effects on the health of mothers and fetuses. To investigate the effect of exercise during pregnancy on the occurrence of GDM among normal-weight pregnant women. We searched for studies published between January 1994 and June 2017 that appeared in the Web of Science, Scopus, ClinicalTrials.gov or Cochrane library databases. Randomized controlled trials that investigated the preventive effect of exercise on GDM in normal-weight women were included. Interventions including any confounding factors (e.g., dietary) were excluded. We extracted maternal characteristics, the diagnostic criteria of GDM, and basic information for intervention and obstetric outcomes. The primary outcome was the occurrence of GDM, and the secondary outcomes included gestational weight gain, gestational age at birth, birth weight, and the odds of cesarean section. A meta-analysis was conducted based on calculations of pooled estimates using the random-effects model. Eight studies were included in this systematic review and meta-analysis. Exercise during pregnancy was shown to decrease the occurrence of GDM [RR = 0.58, 95% CI (0.37, 0.90), P = 0.01 and RR = 0.60, 95% CI (0.36, 0.98), P = 0.04 based on different diagnosis criteria, respectively] in normal-weight women. Regarding secondary outcomes, exercise during pregnancy can decrease gestational weight gain [MD = − 1.61, 95% CI (− 1.99, − 1.22), P<0.01], and had no significant effects on gestational age at birth [MD = − 0.55, 95% CI (− 1.57, 0.47), P = 0.29], birth weight [MD = − 18.70, 95% CI (− 52.49, 15.08), P = 0.28], and the odds of caesarean section [RR = 0.88, 95% CI (0.72, 1.08), P = 0.21], respectively. Exercise during pregnancy can ostensibly decrease the occurrence of GDM without reducing gestational age at delivery and increasing the odds of cesarean section in normal-weight women.
- 12 November 2018
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 18 (1) , 1-9
Open AccessThe effect of exercise during pregnancy on gestational diabetes mellitus in normal-weight women: a systematic review and meta-analysis
Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy, and it has both short- and long-term adverse effects on the health of mothers and fetuses. To investigate the effect of exercise during pregnancy on the occurrence of GDM among normal-weight pregnant women. We searched for studies published between January 1994 and June 2017 that appeared in the Web of Science, Scopus, ClinicalTrials.gov or Cochrane library databases. Randomized controlled trials that investigated the preventive effect of exercise on GDM in normal-weight women were included. Interventions including any confounding factors (e.g., dietary) were excluded. We extracted maternal characteristics, the diagnostic criteria of GDM, and basic information for intervention and obstetric outcomes. The primary outcome was the occurrence of GDM, and the secondary outcomes included gestational weight gain, gestational age at birth, birth weight, and the odds of cesarean section. A meta-analysis was conducted based on calculations of pooled estimates using the random-effects model. Eight studies were included in this systematic review and meta-analysis. Exercise during pregnancy was shown to decrease the occurrence of GDM [RR = 0.58, 95% CI (0.37, 0.90), P = 0.01 and RR = 0.60, 95% CI (0.36, 0.98), P = 0.04 based on different diagnosis criteria, respectively] in normal-weight women. Regarding secondary outcomes, exercise during pregnancy can decrease gestational weight gain [MD = − 1.61, 95% CI (− 1.99, − 1.22), P<0.01], and had no significant effects on gestational age at birth [MD = − 0.55, 95% CI (− 1.57, 0.47), P = 0.29], birth weight [MD = − 18.70, 95% CI (− 52.49, 15.08), P = 0.28], and the odds of caesarean section [RR = 0.88, 95% CI (0.72, 1.08), P = 0.21], respectively. Exercise during pregnancy can ostensibly decrease the occurrence of GDM without reducing gestational age at delivery and increasing the odds of cesarean section in normal-weight women.